Research Interest: Heterocyclic chemistry dealing with Pyrazole, 1,2,4-Triazine.

Research Interest: Physical and organic chemistry; Photochemistry; Organic synthesis; Photo-catalysis; Chemo-sensors

Research Interest: Medicinal Chemistry and Natural products: isolation, structure determination, biotransformation, synthesis of structural analogues, biological valorization, structure activity relationship.Heterocyclic Organic Synthesis and biological valorization.

Research Interest: Adenosine receptor antagonists, Medicinal and organic chemistry of N-heterocycles. Microwave irradiation in heterocyclic synthesis

Research Interest: Molecular modelling and computer-aided drug design,Synthesis and characterisation of biologicaly active heterocyclic compounds.

Dr. Surya Kanta Swain is now working as a Professor and Head of the Institution at Amity Institute of Pharmacy, Amity University Kolkata, West Bengal, India. Dr. Swain had previously served as Dean (Pharmacy & Research) at K.K. University in Nalanda, as well as Dean of Research, Principal (Pharmacy), and Associate Dean of the School of Health Sciences at The Assam Kaziranga University (NAAC Accredited), Assam, which included 14 different programs and 9 Departments. Dr. Swain has established one AMC center under PvPI, 12 laboratory infrastructures, Increased the 60 to 100 intake capacity of the B.Pharm Course, and introduced lateral entry for B.Pharm course & 5 new emerging P.G. programs such as Master in Optometry, M.Sc. Microbiology/Clinical Research, Master in MLT (Medical Microbiology), MPT (Neurology and Orthopedics) and the design of course structure and syllabi for the need of the North Eastern Region of India based on course/program/program specific outcomes at the Assam Kaziranga University.

Dr. Swain has published more than 135 Research/Review/Editorial/Opinion Articles of Scopus/SCI-E/Web of Science/JCR/UGC care listed peer-reviewed/impact factor International/National Journals of Springer/Elsevier/Taylor & Francis/Informa Health care/Bentham Science etc. with the highest impact factor of 14.7 (Acta Pharmaceutica Sinica B Journal), total cumulative impact Factor > 100, total Google Scholar Citations: 2978, H-Index=26 and i¹⁰-Index=44, Total Scopus Citations: 1736, Scopus H-Index=21, and Research Gate Score: 30 with Core Research Domain Area of QbD Enabled Formulation Design, Optimization and Characterization of Mucoadhesive/Self-Emulsifying/Gastro-retentive/Transdermal/Nanoparticulate Drug Delivery Systems.

Dr. Swain delivered scientific talks & attended more than 100 AICTE/DST/DBT/PCI/ICMR/UGC sponsored National and International Seminars/Conferences/Workshops/FDPs/SDPs/STTPs/Webinar as an Invited Speaker/Resource Person/Guest Lecture/Guest of Honor/Adjudicators etc. He is a life member of several professional bodies such as FIC/APTI/IPA/HAB/IPGA/ISPOR and Members of Reviewer MS Research Australia, Research Management Council, Australia, Member Healthcare Advisory Board (HAB), Canada, ABM International Science and Technology Development INC, Baltimore, USA, Community Member of the Global Community of Information Professionals, Canada, Member of the Pharmacy One Source Community, USA-2013, Asian Science Council Editor, Canada, Registered Member of Odisha State Board of Pharmacy Council, Member of PCI Panel, EC Member of Bihar APTI State Branch, etc. He is the Scientific Advisor, Dr. Sethi’s Laboratories Pvt. Ltd. is a Pharmaceutical and Nutraceutical Innovation Company, supported by DBT-BIRAC, Syncorp Health care limited etc.

Research Interest: Mucoadhesive DDS, Selfemulsifying DDS, Transdermal DDS, Liposomal DDS and Controlled DDS.

Research Interest: QSAR, DFT, Transition State Theory, Ab initio Methods, electronic structure, reactivity indices

Research Interest: Phenolic content and antioxydant activity of medicinal plants, Anti-inflammatory, analgesic and antipyretic activities of medicinal plants, Mutagenic and anticancer effects of medicinal plants. NF-κB pathway inhibition, Antileishmanial and antitrypanosomal activities of medicinal plants, Antioxidant, anticancer, mutagenic, Anti-inflammatory, Analgesic, Antipyretic, Antiparasitic, Polyphenols, Flavonoïds, medicinal plants 

Research Interest: Stability studies of new drug substances and new drug products including nanomedicine; Quality assurance; Analytical and bioanalytical method validation; Physicochemical charaterization of new drug substances and new drug products including nanomedicine.

Research Interest: Residue upgrading, whole crude upgrading, desulphurization and demetallation of crudes and their fractions,Chemistry of asphaltenes, crude oils, asphalt and their fractions. Aging and polymer modification studies of asphalts. Recycling of waste plastics, degradation of organic pollutants.